Lifecore Biomedical, Inc. (LFCR) stock
LFCRNasdaqPharmaceutical PreparationsFiscal year ends May 25
$6.40+0.01 (+0.16%)
Close on Nov 18, 2026Market cap $242.26MP/E –Yield –
Lifecore Biomedical free cash flow
Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.
Lifecore Biomedical's free cash flow for the twelve months ending May 25, 2025 was -$13.62M. For fiscal 2025 it was -$13.62M. The highest annual figure on record is $16.81M in fiscal 2012.
Annual free cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | May 25, 2025 | -$13.62M | – |
| FY2024 | May 26, 2024 | -$18.14M | – |
| FY2022 | May 29, 2022 | -$48.82M | – |
| FY2021 | May 30, 2021 | -$2.79M | – |
| FY2020 | May 31, 2020 | -$29.26M | – |
| FY2019 | May 26, 2019 | -$28.71M | – |
| FY2018 | May 27, 2018 | -$13.81M | -302.1% |
| FY2017 | May 28, 2017 | $6.84M | – |
| FY2016 | May 29, 2016 | -$18.93M | -307.9% |
| FY2015 | May 31, 2015 | $9.11M | +47.9% |
| FY2014 | May 25, 2014 | $6.16M | -50.1% |
| FY2013 | May 26, 2013 | $12.35M | -26.5% |
| FY2012 | May 27, 2012 | $16.81M | +115.9% |
| FY2011 | May 29, 2011 | $7.79M | +239.8% |
| FY2010 | May 30, 2010 | $2.29M | – |
Quarterly free cash flow
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2025CQ2 2025 | May 25, 2025 | $3.25M | -45.9% |
| Q3 FY2025CQ1 2025 | Feb 23, 2025 | -$4.26M | – |
| Q2 FY2025CQ4 2024 | Nov 24, 2024 | -$8.58M | – |
| Q1 FY2025CQ3 2024 | Aug 25, 2024 | -$4.04M | – |
| Q4 FY2024CQ2 2024 | May 26, 2024 | $6.00M | – |
| Q3 FY2024CQ1 2024 | Feb 25, 2024 | -$7.79M | – |
| Q2 FY2024CQ4 2023 | Nov 26, 2023 | -$2.97M | – |
| Q1 FY2024CQ3 2023 | Aug 27, 2023 | -$13.38M | – |
| Q3 FY2023CQ1 2023 | Feb 26, 2023 | -$18.83M | – |
| Q2 FY2023CQ4 2022 | Nov 27, 2022 | -$6.20M | – |
| Q1 FY2023CQ3 2022 | Aug 28, 2022 | -$4.46M | – |
| Q4 FY2022CQ2 2022 | May 29, 2022 | -$9.54M | – |
| Q3 FY2022CQ1 2022 | Feb 27, 2022 | -$22.84M | – |
| Q2 FY2022CQ4 2021 | Nov 28, 2021 | -$9.91M | – |
| Q1 FY2022CQ3 2021 | Aug 29, 2021 | -$6.53M | -151.8% |
| Q4 FY2021CQ2 2021 | May 30, 2021 | -$2.80M | – |
| Q3 FY2021CQ1 2021 | Feb 28, 2021 | -$11.05M | -345.7% |
| Q2 FY2021CQ4 2020 | Nov 29, 2020 | -$1.55M | – |
| Q1 FY2021CQ3 2020 | Aug 30, 2020 | $12.60M | – |
| Q4 FY2020CQ2 2020 | May 31, 2020 | -$2.80M | – |
| Q3 FY2020CQ1 2020 | Feb 23, 2020 | $4.50M | – |
| Q2 FY2020CQ4 2019 | Nov 24, 2019 | -$15.53M | – |
| Q1 FY2020CQ3 2019 | Aug 25, 2019 | -$15.42M | – |
| Q4 FY2019CQ2 2019 | May 26, 2019 | -$13.02M | – |
| Q3 FY2019CQ1 2019 | Feb 24, 2019 | -$1.91M | -121.2% |
| Q2 FY2019CQ4 2018 | Nov 25, 2018 | -$1.53M | -158.3% |
| Q1 FY2019CQ3 2018 | Aug 26, 2018 | -$12.25M | – |
| Q4 FY2018CQ2 2018 | May 27, 2018 | -$13.38M | – |
| Q3 FY2018CQ1 2018 | Feb 25, 2018 | $9.00M | -58.8% |
| Q2 FY2018CQ4 2017 | Nov 26, 2017 | $2.63M | -63.0% |
| Q1 FY2018CQ3 2017 | Aug 27, 2017 | -$2.28M | -129.1% |
| Q4 FY2017CQ2 2017 | May 28, 2017 | -$6.86M | -961.6% |
| Q3 FY2017CQ1 2017 | Feb 26, 2017 | $21.88M | – |
| Q2 FY2017CQ4 2016 | Nov 27, 2016 | $7.11M | – |
| Q1 FY2017CQ3 2016 | Aug 28, 2016 | $7.84M | – |
| Q4 FY2016CQ2 2016 | May 29, 2016 | $796.00K | – |
| Q3 FY2016CQ1 2016 | Feb 28, 2016 | -$6.81M | – |
See a number that looks wrong?